Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Becton Dickinson and Company (BDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 66,416,416
  • Shares Outstanding, K 267,560
  • Annual Sales, $ 12,093 M
  • Annual Income, $ 1,100 M
  • 36-Month Beta 1.13
  • Price/Sales 5.52
  • Price/Cash Flow 17.68
  • Price/Book 3.12

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 2.93
  • Number of Estimates 12
  • High Estimate 2.98
  • Low Estimate 2.90
  • Prior Year 2.40
  • Growth Rate Est. (year over year) +22.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
239.80 +4.42%
on 08/02/18
253.77 -1.33%
on 08/09/18
+3.30 (+1.34%)
since 07/13/18
3-Month
218.60 +14.55%
on 05/29/18
253.77 -1.33%
on 08/09/18
+23.22 (+10.22%)
since 05/14/18
52-Week
191.53 +30.74%
on 09/21/17
253.77 -1.33%
on 08/09/18
+48.63 (+24.10%)
since 08/14/17

Most Recent Stories

More News
Becton, Dickinson Global Foothold Strong, Recalls Rampant

Becton, Dickinson (BDX) gains from solid global foothold in Q3; foreign exchange headwinds raise concern.

BDX : 250.40 (+0.87%)
MDT : 91.05 (+0.34%)
ISRG : 529.00 (+1.66%)
INGN : 231.24 (+2.21%)
Becton Dickinson (BDX) Breaks Through Resistance at $248.78

Shares of Becton Dickinson (NYSE:BDX) opened today above their pivot of $247.98 and have already reached the first level of resistance at $248.78. Should the shares continue to rise, the resistance pivots...

BDX : 250.40 (+0.87%)
After Yesterday's Decline of 2.73%, Becton Dickinson Offers Investors Better Value

Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $239.80 to a high of $247.06. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of $246.14...

BDX : 250.40 (+0.87%)
Look for Shares of Becton Dickinson to Potentially Rebound after Yesterday's 2.73% Sell Off

Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $239.80 to a high of $247.06. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of $246.14...

BDX : 250.40 (+0.87%)
Becton, Dickinson (BDX) Earnings and Revenues Beat in Q3

Becton, Dickinson (BDX) gains from solid segmental and geographical sales in Q3.

ILMN : 330.17 (+0.88%)
TMO : 231.61 (+0.39%)
BDX : 250.40 (+0.87%)
ISRG : 529.00 (+1.66%)
Becton Dickinson (BDX) Tops Q3 Earnings and Revenue Estimates

Becton Dickinson (BDX) delivered earnings and revenue surprises of 2.11% and 0.97%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

BDX : 250.40 (+0.87%)
BD Announces Results For 2018 Third Fiscal Quarter; Raises Fiscal 2018 Revenue Guidance

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.278 billion for the third fiscal quarter ended June 30, 2018. This...

BDX : 250.40 (+0.87%)
Medical Product Earnings Lineup for Aug 2: ABC, BDX & More

Strong R&D focus is likely to be the key driver of the Medical Product space in Q2.

CERN : 64.32 (+0.06%)
ABC : 84.43 (+1.65%)
SYK : 166.21 (+0.06%)
BDX : 250.40 (+0.87%)
RMD : 108.26 (+1.43%)
ISRG : 529.00 (+1.66%)
BD Appoints Simon Campion to Interventional Segment President

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today appointed Simon Campion as executive vice president of BD and president, BD Interventional segment, effective...

BDX : 250.40 (+0.87%)
BD Drives the Future of Immunology Research with Expanded Offerings for Simultaneous RNA and Protein Expression Analysis

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial release of the BD® AbSeq assay to analyze protein expression at the single-cell...

BDX : 250.40 (+0.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade BDX with:

Business Summary

Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories....

See More

Key Turning Points

2nd Resistance Point 253.42
1st Resistance Point 251.91
Last Price 250.40
1st Support Level 248.31
2nd Support Level 246.22

See More

52-Week High 253.77
Last Price 250.40
Fibonacci 61.8% 229.99
Fibonacci 50% 222.65
Fibonacci 38.2% 215.31
52-Week Low 191.53

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar